Office of Educational Affairs, Tufts University School of Medicine, 136 Harrison Avenue, Sackler 317, Boston MA 02111, USA.
Respir Care. 2010 Feb;55(2):198-206; discussion 207-8.
Between 15% and 35% of mechanically ventilated patients fail an initial spontaneous breathing trial. For these patients, 40% of total time on mechanical ventilation is consumed by the weaning process (60% for patients with chronic obstructive pulmonary disease). Longer duration of mechanical ventilation is associated with higher risk of complications and probably with higher mortality. Noninvasive ventilation (NIV) has been used successfully in some forms of acute respiratory failure. Randomized controlled trials have indicated that, in selected patients with chronic obstructive pulmonary disease and acute-on-chronic respiratory failure, NIV can facilitate weaning, reduce the duration of invasive mechanical ventilation, decrease complications, and reduce mortality, compared to weaning on continued invasive ventilation. However, extubation failure resulting in re-intubation is associated with higher mortality, and this mortality risk increases with delay of re-intubation and may not be prevented by application of NIV. Patients extubated to NIV must have careful monitoring by skilled clinicians able to provide timely re-intubation if the patient shows signs of intolerance or worsening respiratory failure.
在接受机械通气的患者中,有 15%至 35%的患者首次自主呼吸试验失败。对于这些患者,机械通气的总时间中有 40%(慢性阻塞性肺疾病患者为 60%)用于脱机过程。机械通气时间延长与并发症风险增加有关,可能与死亡率升高有关。无创通气(NIV)已成功用于某些类型的急性呼吸衰竭。随机对照试验表明,在选择的慢性阻塞性肺疾病和慢性呼吸衰竭急性加重的患者中,与继续接受有创机械通气相比,NIV 可以促进脱机,减少有创机械通气的持续时间,减少并发症,并降低死亡率。然而,导致重新插管的拔管失败与更高的死亡率相关,如果患者出现不耐受或呼吸衰竭恶化的迹象,重新插管的延迟可能会增加这种死亡风险,并且不能通过应用 NIV 来预防。需要由熟练的临床医生对接受 NIV 通气的患者进行仔细监测,如果患者出现不耐受或呼吸衰竭恶化的迹象,能够及时进行重新插管。